You have read all your free articles, to continue reading subscribe to read the rest of this content.
The company has registered Dignitana S.r.l as a new entity in Italy, a wholly-owned subsidiary of Dignitana AB. The entity will function under the leadership of Dignitana AB and with this registration the company can now finalize contracts for the sale of 3 machines in Italy. “We are exciteAlready a subscriber…
Medical device QA/RA specialist company Symbioteq has acquired Key2Compliance, specialized in knowledge and information about CGMP and Quality Systems to the life science industry. Both Symbioteq and Key2Compliance were founded in the 1990's by Tomas Camnell and Anna Lundén, and they will both rAlready a subscriber Login You have read…
The company has received approval for its pulse biopsy system NeoNavia from the US Food and Drug Administration, FDA. “The FDA approval for NeoNavia is a major milestone for NeoDynamics and a stamp of quality for both the product and NeoDynamics as a whole,” says Anna Eriksrud, CEO of NeoDynaAlready…
Oncorena receives a capital injection of 66 million SEK from one of the company’s principal shareholders together with two new investors. Under the terms of the agreement, Oncorena can receive an additional 94 million SEK in the future. The capital will primarily fund Oncorena's first clinical Already a subscriber Login…
